ARTICLE

FindCenter AddIcon

COVID-19 Q&A: Dr. Lawrence Fung on Impacts on the Neurodiverse Community

By Lawrence Fung

As scientists learn more about the novel Coronavirus, the consensus is that even with more effective treatments and possible vaccines, COVID-19 will likely be with us for a long time to come. New ways of working and learning will continue to evolve, and the many varieties of talents and skills will need to be accommodated for full inclusion. That includes the neurodiverse community. For this insight we turn to Dr. Lawrence Fung, Director of the Stanford Neurodiversity Project (SNP), and the Adult Neurodevelopment Clinic, as well as Assistant Professor of Psychiatry and Behavioral Sciences.

Read on med.stanford.edu

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

FindCenter AddIcon
FindCenter Post-Image

I Took Ketamine for My Depression. Things Got Pretty Weird.

My first encounter with ketamine did not go well.

FindCenter AddIcon
FindCenter Post-Image

Ketamine Is Revealing a New Understanding of Depression and the Brain

Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.

FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

FindCenter AddIcon

EXPLORE TOPIC

Neurodiversity